Status:
COMPLETED
An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This prospective, multi-center, observational study will evaluate factors influencing the use of tocilizumab (RoActemra/Actemra) as monotherapy in rheumatoid arthritis patients in real life setting. D...
Eligibility Criteria
Inclusion
- Adult participants, \>/= 18 years of age
- Patients with rheumatoid arthritis for whom the rheumatologist decides to start tocilizumab in combination with DMARD or as monotherapy
Exclusion
- Current participation in a clinical trial in rheumatoid arthritis
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
608 Patients enrolled
Trial Details
Trial ID
NCT01474291
Start Date
January 1 2012
End Date
September 1 2014
Last Update
October 28 2016
Active Locations (119)
Enter a location and click search to find clinical trials sorted by distance.
1
Aix-les-Bains, France, 73106
2
Amiens, France, 80000
3
Amiens, France, 80054
4
Angers, France, 49933